Larimar Therapeutics share price logo

Larimar Therapeutics

NASDAQ: LRMR

Small Cap

$3.79

-0.01

(-0.26%)

as on

Larimar Therapeutics Stock Performance

as on September 19, 2026 at 2:16 pm IST

  • Day's Low

    Day's High

    $3.75
    $3.88
    downward going graph

    1.06%

    Downside

    2.37%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $2.72
    $6.42
    downward going graph

    28.36%

    Downside

    69.39%

    Upside

    downward going graph

Larimar Therapeutics share price movements today

Previous Close
$3.80
Open
$3.82
Volume
2.1M
Market Cap
$408.3M
Day's Low - High
$3.75 - $3.88
52 Week Low - High
$2.72 - $6.42

Larimar Therapeutics Historical Returns

1 Month Return
-10.82 %
3 Month Return
+ 4.12 %
1 Year Return
-9.76 %
3 Year Return
-8.89 %
5 Year Return
-69.99 %

Larimar Therapeutics Stock Fundamentals & Key Indicators

Check Larimar Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$408.3M

EPS (TTM)

-1.99

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-1.91

Industry PE ratio

-6.87

PEG Ratio

0.06831352580392458

EBITDA

-172.3M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-137.39%

Larimar Therapeutics Stock Valuation

Track how Larimar Therapeutics P/E has moved over time to understand its valuation trends.

Larimar Therapeutics in the last 5 years

  • Overview

  • Trends

Lowest (-5.41x)

December 31, 2023

Industry (-6.87x)

December 31, 2025

Today (-1.68x)

December 31, 2025

Highest (-1.68x)

December 31, 2025

LowHigh

Today’s Price to Earnings Ratio: -1.68x

Larimar Therapeutics vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Larimar Therapeutics with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
BUY$408.3M-69.99%-1.910.00%0.00%
BUY$63.1B-63.24%-19.81-12.57%0.00%
BUY$130.1B174.21%29.8186.04%0.00%
BUY$79.7B21.1%18.4884.86%0.48%

Stock Returns calculator for Larimar Therapeutics Stock including INR - Dollar returns

The Larimar Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Larimar Therapeutics investment value today

Current value as on today

₹98,207

Returns

-₹1,793

(-1.79%)

Returns from Larimar Therapeutics Stock

-₹9,762 (-9.76%)

Dollar Impact

₹7,969 (+7.97%)

Analyst Recommendation on Larimar Therapeutics Stock

Based on 8 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 8 analysts, 100% of analysts recommend a 'BUY' rating for Larimar Therapeutics. Average target price of $14.4

Larimar Therapeutics Share Price Target

Get share price movements and forecasts by analysts on Larimar Therapeutics.

What analysts predicted

73.68%UPSIDE

Target Price

$14.4

Current Price

$3.79

Analyzed by

8 Analysts

Target

$14.40

Larimar Therapeutics target price $14.4, a slight upside of 73.68% compared to current price of $3.79. According to 8 analysts rating.

Indian Investors' Interest in Larimar Therapeutics Stock

Search interest for Larimar Therapeutics Stock has decreased by -51% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-51% versus previous 30 day period

Larimar Therapeutics Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
0
-
-
-
-
-
-
-
-
-
Operating Income
-16
-24
-18
-31
-31
-27
-49
-64
-31
-34
EBITDA
-14
-21
-15
-28
-29
-26
-47
-62
-29
-32
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-14
-21
-15
-28
-29
-26
-47
-62
-29
-32
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-14
-21
-15
-28
-29
-26
-47
-62
-29
-32
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Larimar Therapeutics Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
-
-
-
-
-
Gross Profit
0
0
0
0
-
-
-
-
-
Operating Income
-53
-62
-23
-42
-50
-36
-41
-90
-172
EBITDA
-52
-60
-23
-42
-50
-35
-36
-80
-165
Interest Expense
0
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
Income Before Tax
-52
-62
-23
-42
-50
-35
-36
-80
-165
Income Tax Expense
0
-1
-
-
-
-
-
-
-
Net Income
-52
-61
-23
-42
-50
-35
-36
-80
-165
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Larimar Therapeutics Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-14
-21
-15
-28
-29
-26
-47
-62
-29
-32
Operating Cash Flow
-10
-13
-24
-21
-26
-19
-28
-38
-44
-44
Investing Cash Flow
-68
-63
27
19
14
18
33
34
29
-40
Financing Cash Flow
162
0
0
0
-
-
65
0
108
0
Change in Cash
83
-77
2
-2
-12
0
69
-4
92
-85

Larimar Therapeutics Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-52
-61
-23
-42
-50
-35
-36
-80
-165
Operating Cash Flow
-43
-51
-22
-42
-42
-27
-33
-70
-113
Investing Cash Flow
35
-6
0
17
24
-90
33
-85
100
Financing Cash Flow
16
66
19
93
19
75
0
161
65
Change in Cash
8
8
-48
68
1
-43
0
5
52

Mutual Funds that own Larimar Therapeutics Stock

Check out the Mutual Funds with significant holdings in Larimar Therapeutics.

Funds
Holdings
Shares Held
VANGUARD INDEX FUNDS
2.692805%
2797365
Fidelity Salem Street Trust
0.512446%
532344
Fidelity Concord Street Trust
0.435232%
452132
Driehaus Mutual Funds
0.329003%
341778
Goldman Sachs Trust
0.275846%
286557

Global Institutional Holdings in Larimar Therapeutics

Funds
Holdings
James E. Flynn
34.28%
Peter Kolchinsky
5.82%
Vanguard
3.41%
iShares
3.07%
Richard Driehaus
3.05%

Insights on Larimar Therapeutics

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 510.3% return, outperforming this stock by 520.1%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Moderna, Inc. Common Stock has given 44.3% return, outperforming this stock by 53.2%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 month, LRMR stock has moved down by -10.8%

About Larimar Therapeutics

Headquartered in Bala Cynwyd, Pennsylvania, Larimar Therapeutics, Inc. operates as a clinical-stage biotechnology firm. Its core mission involves crafting therapies for rare diseases, leveraging a distinctive cell-penetrating peptide technology platform. The company's foremost experimental therapy, CTI-1601, is presently undergoing Phase 1 clinical trials. This drug candidate is being developed to combat Friedreich's ataxia, a genetic illness that is rare, relentlessly progressive, and ultimately fatal.
OrganisationLarimar Therapeutics
HeadquartersThree Bala Plaza East, Bala Cynwyd, PA, 19004, US
IndustryBiotechnology
CEOCarole S. Ben-Maimon
E-voting on sharesClick here to vote

Key Management of Larimar Therapeutics

Name

Title

Mr. John Berman

Vice President of Finance & Administration

Ms. Jennifer Spokes Johansson

Vice President of Legal & Compliance

Dr. Russell G. Clayton Sr., D.O.

Chief Medical Officer

Mr. Francis Michael Conway CPA

VP & Controller

Dr. Carole S. Ben-Maimon M.D.

CEO, President & Director

Mr. Michael Celano CPA

Secretary & CFO

Dr. Gopi Shankar M.B.A., Ph.D.

Chief Development Officer

FAQs

What is Larimar Therapeutics share price today?

Larimar Therapeutics share price today is $3.79 as on at the close of the market. Larimar Therapeutics share today touched a day high of $3.88 and a low of $3.75.

What is the 52 week high and 52 week low for Larimar Therapeutics share?

Larimar Therapeutics share touched a 52 week high of $6.42 on and a 52 week low of $2.72 on . Larimar Therapeutics stock price today i.e. is closed at $3.79,which is 40.97% down from its 52 week high and 39.59% up from its 52 week low.

What is Larimar Therapeutics's market capitalisation today?

Larimar Therapeutics market capitalisation is $0.00T as on .

How to invest in Larimar Therapeutics Stock (LRMR) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Larimar Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Larimar Therapeutics Shares that will get you 0.3958 shares as per Larimar Therapeutics share price of $3.79 per share as on September 19, 2026 at 8:46 am IST.

What is the minimum amount required to buy Larimar Therapeutics Stock (LRMR) from India?

Indian investors can start investing in Larimar Therapeutics (LRMR) shares with as little as ₹95.88 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹958.80 in Larimar Therapeutics stock (as per the Rupee-Dollar exchange rate as on ). Based on Larimar Therapeutics share’s latest price of $3.79 as on September 19, 2026 at 8:46 am IST, you will get 2.6385 shares of Larimar Therapeutics. Learn more about fractional shares .

What are the returns that Larimar Therapeutics has given to Indian investors in the last 5 years?

Larimar Therapeutics stock has given -69.99% share price returns and 30.29% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?